Zobrazeno 1 - 3
of 3
pro vyhledávání: '"J Daniel Cuevas"'
Autor:
Stephanie Mendez, J. Daniel Cuevas, Gabrielle B. Rocque, Joanne L. Blum, Jennifer M. Specht, Steven W. Corso, Yao Wang, Joseph C. Cappelleri, Jawad E Francis, Debu Tripathy, Veneta Pope
Publikováno v:
Cancer Research. 81:SS2-10
Background: The COVID-19 pandemic is negatively affecting patient enrollment, therapy administration, and patient visits in breast cancer clinical trials worldwide. COVID-19 may have a lasting impact on how clinical trials are conducted, and guidelin
Autor:
Abraham Chachoua, Cecile B. Mather, Luiz E Raez, Chandra P. Belani, Rebecca J. Benner, Peter D Eisenberg, John Nemunaitis, J Daniel Cuevas, Sandra J. Meech
Publikováno v:
Cancer Biology & Therapy. 14:557-563
This phase 2 study assessed PF-3512676 plus erlotinib in patients with epidermal growth factor receptor-positive advanced non-small cell lung cancer after prior chemotherapy failure. Patients were randomized 1:1 to PF-3512676 (0.20 mg/kg injected sub
Autor:
Thomas Ervin, J. Daniel Cuevas, Ian W. Flinn, Ralph V. Boccia, Dianna Shipley, Jesus G. Berdeja, Douglas Flora, D. S. Thompson
Publikováno v:
Blood. 126:1492-1492
Introduction: Rituximab and bendamustine combination regimens have demonstrated high activity in non-Hodgkin's lymphoma (NHL). Phase III trials evaluating bendamustine plus rituximab as first-line therapy for patients (pts) with indolent and mantle c